These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 28549876)

  • 1. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
    Kashyap M; Jaiswal V; Farooq U
    Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes.
    Khan MAA; Ami JQ; Faisal K; Chowdhury R; Ghosh P; Hossain F; Abd El Wahed A; Mondal D
    Parasit Vectors; 2020 Apr; 13(1):196. PubMed ID: 32295617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analyses of immunogenic T-cell epitopes of LeIF and PpSP15 proteins from Leishmania major and sand fly saliva used as model antigens for the design of a multi-epitope vaccine to control leishmaniasis.
    Bordbar A; Bagheri KP; Ebrahimi S; Parvizi P
    Infect Genet Evol; 2020 Jun; 80():104189. PubMed ID: 31931259
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bhowmik D; Bhuyan A; Gunalan S; Kothandan G; Kumar D
    J Biomol Struct Dyn; 2024 Nov; 42(18):9731-9752. PubMed ID: 37655736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects.
    Vijayamahantesh ; Amit A; Dikhit MR; Singh AK; Venkateshwaran T; Das VNR; Das P; Bimal S
    Microbes Infect; 2017 Jun; 19(6):358-369. PubMed ID: 28373107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopes.
    Amit A; Dikhit MR; Mahantesh V; Chaudhary R; Singh AK; Singh A; Singh SK; Das VN; Pandey K; Ali V; Narayan S; Sahoo GC; Das P; Bimal S
    J Biomol Struct Dyn; 2017 Jan; 35(1):128-140. PubMed ID: 26727289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
    Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
    Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate.
    Tandon R; Chandra S; Baharia RK; Misra P; Das S; Rawat K; Siddiqi MI; Sundar S; Dube A
    Parasitology; 2018 Apr; 145(4):508-526. PubMed ID: 28691653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome based screening of epitope ensemble vaccine candidates against dreadful visceral leishmaniasis using immunoinformatics approach.
    Singh G; Pritam M; Banerjee M; Singh AK; Singh SP
    Microb Pathog; 2019 Nov; 136():103704. PubMed ID: 31479726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response.
    Nico D; Claser C; Borja-Cabrera GP; Travassos LR; Palatnik M; Soares IS; Rodrigues MM; Palatnik-de-Sousa CB
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e866. PubMed ID: 21085470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the immunomodulatory responses of LdODC-derived MHC Class-II restricted peptides against VL.
    Pandey R; Dikhit MR; Kumar A; Dehury B; Pandey K; Topno RK; Das P; Bimal S
    Parasite Immunol; 2020 Apr; 42(4):e12699. PubMed ID: 31976563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing of precise vaccine construct against visceral leishmaniasis through predicted epitope ensemble: A contemporary approach.
    Singh G; Pritam M; Banerjee M; Singh AK; Singh SP
    Comput Biol Chem; 2020 Jun; 86():107259. PubMed ID: 32339913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class II MHC/peptide interaction in Leishmania donovani infection: implications in vaccine design.
    Roy K; Naskar K; Ghosh M; Roy S
    J Immunol; 2014 Jun; 192(12):5873-80. PubMed ID: 24850723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules.
    Saraav I; Pandey K; Sharma M; Singh S; Dutta P; Bhardwaj A; Sharma S
    Infect Genet Evol; 2016 Oct; 44():182-189. PubMed ID: 27389362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response.
    Dikhit MR; Das S; Mahantesh V; Kumar A; Singh AK; Dehury B; Rout AK; Ali V; Sahoo GC; Topno RK; Pandey K; Das VNR; Bimal S; Das P
    Sci Rep; 2018 Sep; 8(1):14175. PubMed ID: 30242172
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Khan N; Bin-Mwena MN; Alruways MW; Allehyani NMM; Alanzi MO; Shahzad ; Khan A; Sehgal R; Tripathi PK; Farooq U
    J Vector Borne Dis; 2022; 59(2):154-162. PubMed ID: 36124481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis.
    Dikhit MR; ; Kumar A; Amit A; Dehury B; Nathsharma YP; Ansari MY; Ali V; Topno RK; Das V; Pandey K; Sahoo GC; Bimal S; Das P
    J Cell Biochem; 2018 Jan; 119(1):378-391. PubMed ID: 28585770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metadherin peptides containing CD4(+) and CD8(+) T cell epitopes as a therapeutic vaccine candidate against cancer.
    Dhiman G; Lohia N; Jain S; Baranwal M
    Microbiol Immunol; 2016 Sep; 60(9):646-52. PubMed ID: 27554419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.